Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia.

BMC psychiatry

Volumn 9, Issue , 2009, Pages 54-

  Faries, Douglas E ^a   Ascher Svanum, Haya ^a   Nyhuis, Allen W ^a   Kinon, Bruce J ^a  

^a Lilly USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AMBULATORY CARE; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CRISIS INTERVENTION; CROSSOVER PROCEDURE; DRUG ADMINISTRATION; DRUG COST; ECONOMICS; EMERGENCY HEALTH SERVICE; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; MALE; METHODOLOGY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; STATISTICS; UTILIZATION REVIEW;

ADULT; AMBULATORY CARE; ANTIPSYCHOTIC AGENTS; COST-BENEFIT ANALYSIS; CRISIS INTERVENTION; CROSS-OVER STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUG COSTS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; MALE; SCHIZOPHRENIA;

MLCS; MLOWN;

EID: 70349576915     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244x-9-54     Document Type: Article

References (0)